AGO TUMOR FOR DUMMIES

Molecular typing is based on molecular genetic screening and is not still routinely accessible. Molecular subtypes and immunohistochemical surrogate markers of your tumors (HR, HER2, triple destructive) correlate in about 70%. The differentiation of luminal A and B subtypes by HR position and proliferation markers like Ki-sixty seven may very well